Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
87 hedge funds and large institutions have $85.1M invested in Gritstone bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 39 reducing their positions, and 48 closing their positions.
3% more call options, than puts
Call options by funds: $646K | Put options by funds: $630K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less funds holding
Funds holding: 117 → 87 (-30)
48% less capital invested
Capital invested by funds: $165M → $85.1M (-$79.8M)
58% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 48
62% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.87M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.6M |
| 3 |
Renaissance Technologies
New York
|
+$1.33M |
| 4 |
Millennium Management
New York
|
+$1.28M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.2M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.47M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.32M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.31M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.87M |
GRTS Hedge Fund Activity: Q2 2022 in Review
87 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2022, worth a combined $85.1M — down 48% from $165M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of GRTS and 20 opened new positions — a net loss of 28 holders — while 39 trimmed existing stakes and 15 added.
The largest buyer was Morgan Stanley, adding an estimated $2.87M. The largest seller was BlackRock, cutting an estimated $5.2M.
- 87 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2022, down from 117 in Q1 2022.
- Funds reported $85.1M of Gritstone bio, Inc. Common Stock stock for Q2 2022, down 48% quarter-over-quarter.
- 20 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2022 and 48 closed out, a net change of -28 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q2 2022 was Morgan Stanley, an estimated $2.87M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $5.2M sold.
Based on aggregated 13F filings for Q2 2022.